Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $32.49 | 2 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $20.71 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $11.78 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $32.49 | 2 | Novo Nordisk Inc ($20.71) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/02/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: RESPIRATORY | ||||||
| 01/25/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.71 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 222 | 259 | $29,119 | $12,048 |
| 2022 | 7 | 244 | 284 | $30,567 | $14,039 |
| 2021 | 4 | 186 | 256 | $26,056 | $11,669 |
| 2020 | 15 | 551 | 794 | $85,407 | $25,469 |
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 39 | $6,241 | $2,720 | 43.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 45 | $5,000 | $2,312 | 46.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $5,660 | $2,301 | 40.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $5,042 | $1,996 | 39.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 37 | 38 | $5,325 | $1,541 | 28.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 26 | 52 | $1,201 | $843.44 | 70.2% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 18 | 18 | $414.36 | $291.60 | 70.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 13 | $235.00 | $44.33 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 83 | $9,045 | $4,857 | 53.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 61 | 64 | $7,680 | $2,610 | 34.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 32 | 32 | $5,205 | $2,471 | 47.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 27 | $4,321 | $1,863 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $2,953 | $1,323 | 44.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 26 | 54 | $1,243 | $879.84 | 70.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 12 | $120.00 | $35.58 | 29.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 116 | 186 | $15,773 | $6,034 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 45 | 45 | $9,815 | $5,396 | 55.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 11 | 11 | $349.14 | $197.34 | 56.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 14 | 14 | $120.00 | $42.00 | 35.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 119 | 205 | $28,700 | $7,059 | 24.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 56 | 143 | $17,160 | $6,458 | 37.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 87 | 117 | $21,060 | $6,138 | 29.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 15 | 24 | $2,160 | $973.50 | 45.1% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 11 | 11 | $1,650 | $931.55 | 56.5% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 11 | 21 | $1,890 | $885.00 | 46.8% |
About Bianca Chatman
Bianca Chatman is a Registered Nurse healthcare provider based in Richton Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2019. The National Provider Identifier (NPI) number assigned to this provider is 1831653690.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bianca Chatman has received a total of $32.49 in payments from pharmaceutical and medical device companies, with $32.49 received in 2021. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($32.49).
As a Medicare-enrolled provider, Chatman has provided services to 1,203 Medicare beneficiaries, totaling 1,593 services with total Medicare billing of $63,225. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Practice Information
- Specialty Registered Nurse
- Other Specialties Family, Family
- Location Richton Park, IL
- Active Since 01/25/2019
- Last Updated 09/12/2023
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1831653690
Products in Payments
- Ozempic (Drug) $20.71
- TRELEGY ELLIPTA (Drug) $11.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.